DFS | B | P | HR | 95% CI HR | |
---|---|---|---|---|---|
Inf | Sup | ||||
SND (I-IV) | 0.019 | 0.949 | 1.019 | 0.564 | 1.841 |
N stage | 0.185 | ||||
N1 | 0.200 | 0.583 | 1.221 | 0.598 | 2.495 |
N2 | 0.302 | 0.510 | 1.353 | 0.551 | 3.332 |
N3 | 1.357 | 0.030 | 3.883 | 1.140 | 13.224 |
Chemoradiotherapy | 0.727 | 0.041 | 2.068 | 1.029 | 4.155 |
OS | B | P | HR | 95% CI HR | |
Inf | Sup | ||||
SND (I-IV) | -0.131 | 0.731 | 0.878 | 0.418 | 1.845 |
T stage | 0.115 | ||||
T2 | 0.061 | 0.940 | 1.063 | 0.214 | 5.283 |
T3 | 0.957 | 0.223 | 2.605 | 0.559 | 12.142 |
T4 | 0.174 | 0.843 | 1.190 | 0.214 | 6.622 |
Radiotherapy | -0.785 | 0.055 | 0.456 | 0.205 | 1.015 |
Chemoradiotherapy | 0.880 | 0.042 | 2.411 | 1.031 | 5.636 |
DSS | B | P | HR | 95% CI HR | |
Inf | Sup | ||||
SND (I-IV) | 0.353 | 0.354 | 1.424 | 0.674 | 3.007 |
T stage | 0.278 | ||||
T1 | 0.172 | 0.833 | 1.187 | 0.242 | 5.831 |
T2 | 0.847 | 0.280 | 2.332 | 0.502 | 10.823 |
T3 | 0.075 | 0.930 | 1.078 | 0.200 | 5.819 |
Chemoradiotherapy | 0.700 | 0.079 | 2.013 | 0.922 | 4.395 |